ArticleScientific reports2026
A zebrafish multimodal toolbox to study the blood-brain barrier in health and disease.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Vasogenic edema, due to inner blood-retinal barrier (BRB) disruption, is a major cause of vision loss across various ocular diseases. Similarly, blood-brain barrier (BBB) breakdown is a hallmark of many neurological disorders. However, the precise molecular and cellular mechanisms underlying barrier dysfunction under pathological conditions remain poorly understood. In this study, we aimed to develop a pathological model to investigate the integrity of the inner BRB and BBB using in vivo live imaging in zebrafish larvae, employing hyperglycemia-induced leakage as a proof of concept. Our results show that external glucose exposure elevates internal glucose levels, inducing hyperglycemia. Hyperglycemia increased midbrain blood vessel diameter and tracer leakage, indicative of barrier dysfunction, without affecting overall larval survival. Using fluorescent reporters, we found that hyperglycemia concurrently reduced claudin-5 and increased PLVAP, suggesting compromised tight junction integrity and impeded BBB maturation. Preliminary studies using transmission electron microscopy further revealed ultrastructural defects of junctions. However, further optimization is needed to reliably assess differences in caveolae between the experimental groups. This proof of concept study establishes an in vivo protocol for visualizing and quantifying barrier permeability, protein expression, and ultrastructure. It provides a valuable foundation for a zebrafish model to dissect the molecular mechanisms of blood-barrier breakdown, with direct implications for investigations of diabetic macular edema and other neurovascular diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.